MedPage Today on MSN
FDA Tweaks JAK Inhibitor Indication in Inflammatory Bowel Disease
The FDA updated the indication of the JAK inhibitor upadacitinib (Rinvoq) in inflammatory bowel disease (IBD) to account for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback